Yuki Kudo Selected Research

Complement C6 (Complement 6)

8/2022

Moyamoya Disease Associated with a Deficiency of Complement Component 6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Kudo Research Topics

Disease

1	Complement Component 6 Deficiency 08/2022
1	Moyamoya Disease (Moya-Moya Disease) 08/2022
1	Arthritis (Polyarthritis) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Osteoarthritis 01/2020
1	Bile Duct Neoplasms (Bile Duct Cancer) 04/2012
1	Neoplasms (Cancer) 04/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012

Drug/Important Bio-Agent (IBA)

1	Complement C6 (Complement 6)IBA 08/2022
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	Beclin-1IBA 01/2020
1	Anti-Citrullinated Protein AntibodiesIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	arginine deiminaseIBA 01/2020
1	pepstatin (pepstatin A)IBA 01/2020
1	cyclic citrullinated peptideIBA 01/2020
1	Collagen Type II (Type II Collagen)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	DAPIIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	VimentinIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Gemcitabine FDA Link 04/2012